| LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations (NCT01726738) | UNC Lineberger Comprehensive Cancer Center | 2013-04-04 |
| Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart (NCT01849614) | UNC Lineberger Comprehensive Cancer Center | 2013-03-01 |
| PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) (NCT01800032) | UNC Lineberger Comprehensive Cancer Center | 2013-01-16 |
| Metformin for the Treatment of Endometrial Hyperplasia (NCT01685762) | UNC Lineberger Comprehensive Cancer Center | 2013-01-10 |
| Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions (NCT01773850) | UNC Lineberger Comprehensive Cancer Center | 2013-01-01 |
| Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) (NCT01573702) | UNC Lineberger Comprehensive Cancer Center | 2012-12-11 |
| Predicting Tolerance to Radiation Therapy in Older Adults With Cancer (NCT01752751) | UNC Lineberger Comprehensive Cancer Center | 2012-11-01 |
| Clinical Cohort of Lymphoma Patients in Malawi (NCT02835911) | UNC Lineberger Comprehensive Cancer Center | 2012-11-01 |
| Hybrid PET/MR in the Therapy of Cervical Cancer (NCT01759355) | UNC Lineberger Comprehensive Cancer Center | 2012-10-01 |
| Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy (NCT01789983) | UNC Lineberger Comprehensive Cancer Center | 2012-10-01 |
| PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study (NCT01751516) | UNC Lineberger Comprehensive Cancer Center | 2012-10-01 |
| Imaging Correlates of Renal Cell Carcinoma Biological Features (NCT01665703) | UNC Lineberger Comprehensive Cancer Center | 2012-08-01 |
| Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer (NCT01655745) | UNC Lineberger Comprehensive Cancer Center | 2012-07-24 |
| Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer (NCT01776138) | UNC Lineberger Comprehensive Cancer Center | 2012-07-23 |
| Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer (NCT01688323) | UNC Lineberger Comprehensive Cancer Center | 2012-07-01 |
| Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard Induction (NCT01578954) | UNC Lineberger Comprehensive Cancer Center | 2012-06-28 |
| Patient Preferences for Breast Reconstruction After Mastectomy (NCT01488357) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery (NCT01612351) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy (NCT02003417) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer (NCT01571024) | UNC Lineberger Comprehensive Cancer Center | 2012-05-01 |
| Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma (NCT01492881) | UNC Lineberger Comprehensive Cancer Center | 2012-04-01 |
| Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma (NCT01578967) | UNC Lineberger Comprehensive Cancer Center | 2012-04-01 |
| Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI (NCT01605344) | UNC Lineberger Comprehensive Cancer Center | 2012-04-01 |
| Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL (NCT03016377) | UNC Lineberger Comprehensive Cancer Center | 2012-03-22 |
| De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca (NCT01530997) | UNC Lineberger Comprehensive Cancer Center | 2012-02-07 |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT01412229) | UNC Lineberger Comprehensive Cancer Center | 2012-02-01 |
| FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer (NCT01688336) | UNC Lineberger Comprehensive Cancer Center | 2012-01-01 |
| Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 (NCT01467310) | UNC Lineberger Comprehensive Cancer Center | 2012-01-01 |
| Circulating Tumor Cells in Solid Tumors (NCT03161821) | UNC Lineberger Comprehensive Cancer Center | 2011-12-09 |
| Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma (NCT01488487) | UNC Lineberger Comprehensive Cancer Center | 2011-12-01 |
| Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab (NCT01312493) | UNC Lineberger Comprehensive Cancer Center | 2011-12-01 |
| Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30) (NCT01316146) | UNC Lineberger Comprehensive Cancer Center | 2011-10-03 |
| Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions (NCT01457196) | UNC Lineberger Comprehensive Cancer Center | 2011-09-01 |
| A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases (NCT01305941) | UNC Lineberger Comprehensive Cancer Center | 2011-09-01 |
| Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer (NCT01300962) | UNC Lineberger Comprehensive Cancer Center | 2011-08-01 |
| Neoadjuvant Pazopanib in Renal Cell Carcinoma (NCT01361113) | UNC Lineberger Comprehensive Cancer Center | 2011-06-01 |
| Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas (NCT01263418) | UNC Lineberger Comprehensive Cancer Center | 2011-06-01 |
| Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects (NCT01323062) | UNC Lineberger Comprehensive Cancer Center | 2011-05-01 |
| Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer (NCT01911247) | UNC Lineberger Comprehensive Cancer Center | 2011-05-01 |
| Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer (NCT01298570) | UNC Lineberger Comprehensive Cancer Center | 2011-04-07 |
| Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma (NCT01234467) | UNC Lineberger Comprehensive Cancer Center | 2011-03-01 |
| Retinal Oxygen Function After Radiation Therapy (NCT02043470) | UNC Lineberger Comprehensive Cancer Center | 2011-03-01 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201) | UNC Lineberger Comprehensive Cancer Center | 2011-01-07 |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) (NCT02564120) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer (NCT01725048) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab (NCT01262820) | UNC Lineberger Comprehensive Cancer Center | 2010-12-01 |
| Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients (NCT01305954) | UNC Lineberger Comprehensive Cancer Center | 2010-12-01 |
| PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias (NCT01169012) | UNC Lineberger Comprehensive Cancer Center | 2010-09-01 |
| Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer (NCT01175967) | UNC Lineberger Comprehensive Cancer Center | 2010-06-01 |
| Trisenox® in Women With Metastatic Endometrial Cancer (NCT01184053) | UNC Lineberger Comprehensive Cancer Center | 2010-03-01 |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers (NCT01344824) | UNC Lineberger Comprehensive Cancer Center | 2010-03-01 |
| Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy (NCT01164215) | UNC Lineberger Comprehensive Cancer Center | 2010-02-01 |
| Biomarkers in Blood Samples From Older Breast Cancer Survivors (NCT01138345) | UNC Lineberger Comprehensive Cancer Center | 2010-01-01 |
| Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma (NCT01204450) | UNC Lineberger Comprehensive Cancer Center | 2009-11-01 |
| Registry of Older Patients With Cancer (NCT01137825) | UNC Lineberger Comprehensive Cancer Center | 2009-09-01 |
| Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery (NCT01011010) | UNC Lineberger Comprehensive Cancer Center | 2009-07-22 |
| Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy (NCT00998101) | UNC Lineberger Comprehensive Cancer Center | 2009-07-01 |
| Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer (NCT01137643) | UNC Lineberger Comprehensive Cancer Center | 2009-07-01 |
| Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases (NCT01528878) | UNC Lineberger Comprehensive Cancer Center | 2009-04-01 |
| Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy (NCT01132833) | UNC Lineberger Comprehensive Cancer Center | 2008-12-01 |
| Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00744354) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Digital Breast Tomosynthesis Preference Study (NCT00776126) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis (NCT00767468) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen (NCT00764322) | UNC Lineberger Comprehensive Cancer Center | 2008-06-18 |
| Radiation Induced Cardiopulmonary Injury in Humans (NCT02259452) | UNC Lineberger Comprehensive Cancer Center | 2008-06-01 |
| Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment (NCT00610948) | UNC Lineberger Comprehensive Cancer Center | 2008-03-01 |
| Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00577694) | UNC Lineberger Comprehensive Cancer Center | 2007-11-01 |
| Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors (NCT00573690) | UNC Lineberger Comprehensive Cancer Center | 2007-09-01 |
| Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC (NCT00519831) | UNC Lineberger Comprehensive Cancer Center | 2007-08-01 |
| Visibility of Lesion Characteristics With Phase Contrast Mammography (NCT00467727) | UNC Lineberger Comprehensive Cancer Center | 2007-04-01 |
| Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NCT00489216) | UNC Lineberger Comprehensive Cancer Center | 2006-12-01 |
| Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer (NCT00405366) | UNC Lineberger Comprehensive Cancer Center | 2006-11-01 |
| Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer (NCT00483405) | UNC Lineberger Comprehensive Cancer Center | 2006-10-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors (NCT00307255) | UNC Lineberger Comprehensive Cancer Center | 2006-08-01 |
| Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00320073) | UNC Lineberger Comprehensive Cancer Center | 2006-08-01 |
| Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma (NCT00334438) | UNC Lineberger Comprehensive Cancer Center | 2006-07-01 |
| Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer (NCT00380029) | UNC Lineberger Comprehensive Cancer Center | 2006-05-01 |
| Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer (NCT00454324) | UNC Lineberger Comprehensive Cancer Center | 2006-04-01 |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer (NCT00379509) | UNC Lineberger Comprehensive Cancer Center | 2006-04-01 |
| Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC (NCT00283244) | UNC Lineberger Comprehensive Cancer Center | 2006-03-01 |
| Individualized Exercise Programs for Patients Receiving Chemotherapy for Newly Diagnosed Acute or Relapsed Myeloid Leukemia or Lymphoblastic Leukemia (NCT00499759) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy (NCT00486304) | UNC Lineberger Comprehensive Cancer Center | 2006-02-01 |
| Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00280150) | UNC Lineberger Comprehensive Cancer Center | 2006-01-01 |
| Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00266110) | UNC Lineberger Comprehensive Cancer Center | 2005-12-01 |
| Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer (NCT00232505) | UNC Lineberger Comprehensive Cancer Center | 2005-11-01 |
| Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen (NCT00448357) | UNC Lineberger Comprehensive Cancer Center | 2005-10-01 |
| Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00246753) | UNC Lineberger Comprehensive Cancer Center | 2005-10-01 |
| Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme (NCT00227032) | UNC Lineberger Comprehensive Cancer Center | 2005-09-01 |
| Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer (NCT00225420) | UNC Lineberger Comprehensive Cancer Center | 2005-08-01 |
| Effect of Aprepitant on Cyclophosphamide Pharmacokinetics in Patients With Breast Cancer (NCT00719173) | UNC Lineberger Comprehensive Cancer Center | 2005-08-01 |
| Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer (NCT00257426) | UNC Lineberger Comprehensive Cancer Center | 2005-07-01 |
| Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer (NCT00499395) | UNC Lineberger Comprehensive Cancer Center | 2005-07-01 |
| Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer (NCT00280748) | UNC Lineberger Comprehensive Cancer Center | 2005-05-01 |
| Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease (NCT00312637) | UNC Lineberger Comprehensive Cancer Center | 2005-03-01 |
| Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer (NCT00520091) | UNC Lineberger Comprehensive Cancer Center | 2005-03-01 |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors (NCT00520000) | UNC Lineberger Comprehensive Cancer Center | 2004-12-01 |
| Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer (NCT01148875) | UNC Lineberger Comprehensive Cancer Center | 2004-09-01 |
| Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer (NCT00266097) | UNC Lineberger Comprehensive Cancer Center | 2004-08-01 |
| Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC (NCT00280735) | UNC Lineberger Comprehensive Cancer Center | 2004-05-01 |
| Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women (NCT00099008) | UNC Lineberger Comprehensive Cancer Center | 2004-03-01 |